957
Participants
Start Date
October 1, 2015
Primary Completion Date
March 30, 2017
Study Completion Date
April 12, 2017
semaglutide
Once-daily subcutaneous (s.c., under the skin) administration with dose escalation.
liraglutide
Once-daily subcutaneous (s.c., under the skin) administration with dose escalation.
placebo
Once-daily subcutaneous (s.c., under the skin) administration.
Novo Nordisk Investigational Site, Brussels
Novo Nordisk Investigational Site, Camperdown
Novo Nordisk Investigational Site, St Leonards
Novo Nordisk Investigational Site, Merewether
Novo Nordisk Investigational Site, Edegem
Novo Nordisk Investigational Site, Leuven
Novo Nordisk Investigational Site, Melbourne
Novo Nordisk Investigational Site, Heidelberg Heights
Novo Nordisk Investigational Site, Liège
Novo Nordisk Investigational Site, Mons
Novo Nordisk Investigational Site, Rochester
Novo Nordisk Investigational Site, Washington D.C.
Novo Nordisk Investigational Site, Arlington
Novo Nordisk Investigational Site, Richmond
Novo Nordisk Investigational Site, Charleston
Novo Nordisk Investigational Site, Greer
Novo Nordisk Investigational Site, Haifa
Novo Nordisk Investigational Site, Jacksonville
Novo Nordisk Investigational Site, Jacksonville
Novo Nordisk Investigational Site, Plantation
Novo Nordisk Investigational Site, Crystal River
Novo Nordisk Investigational Site, Wadsworth
Novo Nordisk Investigational Site, Kfar Saba
Novo Nordisk Investigational Site, Cincinnati
Novo Nordisk Investigational Site, Duisburg
Novo Nordisk Investigational Site, Petah Tikva
Novo Nordisk Investigational Site, Petah Tikva
Novo Nordisk Investigational Site, Tel Litwinsky
Novo Nordisk Investigational Site, Tel Aviv
Novo Nordisk Investigational Site, Saint Ingbert-Oberwürzbach
Novo Nordisk Investigational Site, Stuttgart
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Sugar Land
Novo Nordisk Investigational Site, Round Rock
Novo Nordisk Investigational Site, Golden
Novo Nordisk Investigational Site, Wangen
Novo Nordisk Investigational Site, Jerusalem
Novo Nordisk Investigational Site, San Diego
Novo Nordisk Investigational Site, Anaheim
Novo Nordisk Investigational Site, Portland
Novo Nordisk Investigational Site, Moscow
Novo Nordisk Investigational Site, Moscow
Novo Nordisk Investigational Site, Moscow
Novo Nordisk Investigational Site, Moscow
Novo Nordisk Investigational Site, Yaroslavl
Novo Nordisk Investigational Site, Yaroslavl
Novo Nordisk Investigational Site, Saint Petersburg
Novo Nordisk Investigational Site, Voronezh
Novo Nordisk Investigational Site, Penza
Novo Nordisk Investigational Site, Tyumen
Novo Nordisk Investigational Site, Novosibirsk
Novo Nordisk Investigational Site, Waterbury
Novo Nordisk Investigational Site, Elkridge
Novo Nordisk Investigational Site, Bristol
Novo Nordisk Investigational Site, Calgary
Novo Nordisk Investigational Site, Surrey
Novo Nordisk Investigational Site, Moncton
Novo Nordisk Investigational Site, Halifax
Novo Nordisk Investigational Site, Hamilton
Novo Nordisk Investigational Site, Hamilton
Novo Nordisk Investigational Site, Toronto
Novo Nordisk Investigational Site, Montreal
Novo Nordisk Investigational Site, Québec
Novo Nordisk Investigational Site, Dresden
Novo Nordisk Investigational Site, Dresden
Novo Nordisk Investigational Site, Leipzig
Novo Nordisk Investigational Site, Bristol
Novo Nordisk Investigational Site, Cambridge
Novo Nordisk Investigational Site, Glasgow
Novo Nordisk Investigational Site, Liverpool
Novo Nordisk Investigational Site, London
Novo Nordisk Investigational Site, Luton
Novo Nordisk Investigational Site, Norwich
Novo Nordisk Investigational Site, Rotherham
Lead Sponsor
Novo Nordisk A/S
INDUSTRY